NeoPharm CO., LTD. (KOSDAQ: 092730)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,860
-120 (-1.00%)
Dec 20, 2024, 9:00 AM KST

NeoPharm CO., LTD. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
112,20097,10585,03387,93181,62583,240
Upgrade
Other Revenue
---0---
Upgrade
Revenue
112,20097,10585,03387,93181,62583,240
Upgrade
Revenue Growth (YoY)
21.60%14.20%-3.30%7.72%-1.94%25.60%
Upgrade
Cost of Revenue
44,30631,72026,65325,54422,98423,136
Upgrade
Gross Profit
67,89465,38558,38062,38658,64260,104
Upgrade
Selling, General & Admin
38,36936,27632,98436,02232,99133,958
Upgrade
Research & Development
3,0352,6472,8542,9352,8022,518
Upgrade
Operating Expenses
42,97940,07836,94139,95536,74037,144
Upgrade
Operating Income
24,91525,30721,43922,43121,90222,961
Upgrade
Interest Expense
-42.54-21.32-8.84-38.46-56.37-17.17
Upgrade
Interest & Investment Income
4,1944,5882,0771,1771,3661,252
Upgrade
Currency Exchange Gain (Loss)
-151.13-117.74205.38662.9-126.0424.92
Upgrade
Other Non Operating Income (Expenses)
-563.91-362.95-376.73-430.38-138.91-424.3
Upgrade
EBT Excluding Unusual Items
28,35129,39323,33523,80122,94723,796
Upgrade
Gain (Loss) on Sale of Investments
-61.22-2.76-48.48--
Upgrade
Gain (Loss) on Sale of Assets
-14.46-3.7-6.05-3.23-10.81-7.28
Upgrade
Asset Writedown
-1.58-13.47-6.23-11.07--250.66
Upgrade
Other Unusual Items
-----2.93
Upgrade
Pretax Income
28,27429,37323,32323,83622,93623,541
Upgrade
Income Tax Expense
5,9406,1606,2966,1224,8054,296
Upgrade
Net Income
22,33423,21317,02717,71318,13119,245
Upgrade
Net Income to Common
22,33423,21317,02717,71318,13119,245
Upgrade
Net Income Growth
7.72%36.33%-3.87%-2.30%-5.79%25.22%
Upgrade
Shares Outstanding (Basic)
161616161615
Upgrade
Shares Outstanding (Diluted)
161616161615
Upgrade
Shares Change (YoY)
----0.95%4.38%5.80%
Upgrade
EPS (Basic)
1427.891484.071088.601132.471159.171284.83
Upgrade
EPS (Diluted)
1427.891484.001088.501132.471148.001272.00
Upgrade
EPS Growth
7.77%36.33%-3.88%-1.35%-9.75%18.33%
Upgrade
Free Cash Flow
-5,8263,41117,70721,36116,78813,322
Upgrade
Free Cash Flow Per Share
-372.46218.061132.041365.691063.18880.60
Upgrade
Dividend Per Share
375.000375.000350.000350.000325.000375.000
Upgrade
Dividend Growth
7.14%7.14%0%7.69%-13.33%15.38%
Upgrade
Gross Margin
60.51%67.33%68.66%70.95%71.84%72.21%
Upgrade
Operating Margin
22.21%26.06%25.21%25.51%26.83%27.58%
Upgrade
Profit Margin
19.91%23.90%20.02%20.14%22.21%23.12%
Upgrade
Free Cash Flow Margin
-5.19%3.51%20.82%24.29%20.57%16.00%
Upgrade
EBITDA
27,68826,98023,05523,93123,39624,169
Upgrade
EBITDA Margin
24.68%27.78%27.11%27.22%28.66%29.04%
Upgrade
D&A For EBITDA
2,7731,6731,6161,5001,4941,209
Upgrade
EBIT
24,91525,30721,43922,43121,90222,961
Upgrade
EBIT Margin
22.21%26.06%25.21%25.51%26.83%27.58%
Upgrade
Effective Tax Rate
21.01%20.97%27.00%25.69%20.95%18.25%
Upgrade
Advertising Expenses
-12,40811,53314,69512,68611,410
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.